Search clinical trials for: Pandemi

Total 1146 results

Institut National de la Santé Et de la Recherche...

Completed

"COhort Study on A/H1N1 FLU During PREGnancy" (COFLUPREG)

Pregnancy | Influenza

France
Sanofi

Completed

Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine

Influenza | Orthomyxoviridae Infections

United States
Assistance Publique - Hôpitaux de Paris
GlaxoSmithKline; Hoffmann-La Roche

Terminated

Evaluation of Efficacity and Safety of Oseltamivir and Zanamivir (BIVIR)

Gastric Influenza

France
Intercell USA, Inc.
Department of Health and Human Services

Completed

A/H5N1 Dose Ranging Study With Adjuvant Patch

Pandemic Influenza

United States
Novartis Vaccines

Completed

Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years

Prophylaxis of Avian Influenza

Finland
Leiden University Medical Center
Erasmus Medical Center

Completed

Vaccination Response in ImmunoCompromised Host. Immune Response After Vaccination Against Pandemic A/H1N1 Influenza (RICH-3)

HIV

Netherlands
Amen Clinics, Inc.

Completed

Single Photon Emission Computed Tomography (SPECT) Imaging Study of Professional American Football Players

Traumatic Brain Injury

United States
Institut National de la Santé Et de la Recherche...
MCM Vaccines B.V.

Completed

Safety and Efficacy of an Inactivated and Non Adjuvanted Vaccine Against Influenza A in Renal Transplant Recipients (Transfluvac)

Immunosuppression | Renal Transplant Recipients

France
Shanghai Institute Of Biological Products

Completed

Immunogenicity and Safety of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine in Infants

Influenza

China
Novartis Vaccines

Completed

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine (Egg-Derived) in Healthy Subjects From 6 Months to 17 Years of Age

Pandemic Influenza

Netherlands, Belgium, Chile, Dominican Republic, Germany
Novartis Vaccines

Completed

Observational Safety and Effectiveness Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine

Influenza A (H1N1)

Italy
St. Jude Children's Research Hospital

Completed

Immunogenicity and Safety of Inactivated H1N1 Swine-origin Influenza Monovalent Vaccine in Immunocompromised Children and Young Adults

H1N1 Pandemic Flu

United States
Novartis Vaccines

Completed

Observational Safety Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine

A New Flu Virus of Swine Origin | Pandemic Influenza A (H1N1)

Argentina, Netherlands
Sanofi

Completed

A Study of Different Formulations of an Adjuvanted A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly

Influenza | Swine-origin A/H1N1 Influenza

United States
Novartis Vaccines

Completed

Novartis Pandemic Influenza A (H1N1) Vaccine(s) Observational Comparative Safety Study

Influenza

Italy, Argentina, Netherlands
The University of Hong Kong

Completed

Direct and Indirect Benefits of Influenza Vaccination in Schools and Households

Acute Respiratory Infection | Influenza-like Illness | Influenza Virus Infection

Hong Kong
Dalhousie University
Canadian Institutes of Health Research (CIHR)

Unknown

Outcomes of Pandemic Influenza in Pregnancy

Influenza

Canada
UMN Pharma Inc.

Completed

Immunogenicity and Safety Study of a Booster Vaccination With a Recombinant H5N1 Influenza HA Vaccine in Primed Adults

Influenza

Japan
Makerere University
Health Research Board, Ireland

Unknown

Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients

HIV Infections | Tuberculosis

Uganda
University of Oxford
Genzyme, a Sanofi Company; Oxford University Hospitals NHS Trust

Unknown

Thymoglobulin Induction in Kidney Transplant Recipients (TIKT)

Kidney Transplantation | Ischemia-Reperfusion Injury

United Kingdom
Medicago

Completed

Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults

RNA Virus Infections | Virus Diseases | Respiratory Tract Infections | Respiratory Tract Diseases

Canada
National Institute of Allergy and Infectious Diseases...

Completed

Influenza Immunity Against Pandemic Respiratory Virus

Influenza

United States
Mount Sinai Hospital, Canada

Terminated

The Pandemic Stress Vaccine: A Resource to Enhance the Resilience of Healthcare Workers Facing an Infectious Outbreak

Psychological Stress

Canada
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Unknown

Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases

Rheumatoid Arthritis | Systemic Vasculitis | Juvenile Idiopathic Arthritis | Antiphospholipid Syndrome | Sjögren's Syndrome | Spondyloarthritis | Systemic Lupus Erythematosus (SLE) | Systemic Sclerosis (SSc) | Dermatomyositis (DM) | DMixed Connective Tissue Disease | Juvenile SLE | Juvenile DM

Brazil
Centers for Disease Control and Prevention
PATH; World Health Organization; MCM Vaccines B.V.; Pan American Health Organization and other collaborators

Completed

Needle-free Jet Injection of Reduced-dose, Intradermal, Influenza Vaccine in >= 6 to < 24-month-old Children

Influenza

Dominican Republic
Beijing Ditan Hospital
China Academy of Chinese Medical Sciences; Beijing University of Chinese Medicine and other collaborators

Unknown

A Pragmatic Randomized Controlled Trial of Chinese Herbal Medicine for Severe Pandemic H1N1 Influenza (200907001-2A)

Influenza A Virus, H1N1 Subtype

China
University Health Network, Toronto
Princess Margaret Hospital, Canada

Completed

Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy

Lymphoma | Multiple Myeloma | Influenza A Virus, H1N1 Subtype

Canada
Institut National de la Santé Et de la Recherche...

Unknown

Study of Immune Responses After Vaccination Against Seasonal Influenza Virus and Against Influenza H1N1-v Pandemic Virus in a Medical Staff. (FLU-HOP)

Influenza A Virus, H1N1 Subtype

France
UMN Pharma Inc.

Completed

Immunogenicity, Safety and Optimal Dose Finding Study of Recombinant Influenza H5N1 Vaccine in Healthy Young Adults

Virus Diseases | Influenza

Japan
Shanghai Public Health Clinical Center
Beijing Ditan Hospital; National Institute for the Control of Pharmaceutical...

Unknown

Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients

Virus Diseases | Respiratory Tract Infections | Respiratory Tract Diseases | Influenza | Orthomyxoviridae Infections

China
Hadassah Medical Organization

Unknown

Assessment of Safety and Immunogenicity of Intradermal Unadjuvanted Portion of Pandemrix® Via a Microneedle Device With Intramuscular Adjuvanted Pandemrix® as Reference

Healthy

Israel
Hadassah Medical Organization

Unknown

Antibody Production Following H1N1 Influenza Vaccination After Stem Cell and Heart Transplantation

H1N1 Influenza

Israel
University of British Columbia

Withdrawn

Rapid Evaluation of Seasonal Influenza Vaccine

Influenza

Canada
Sinovac Biotech Co., Ltd
Centers for Disease Control and Prevention, China

Completed

Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Adolescents

Influenza

China
Vanderbilt University

Completed

Tocopherols and Alpha Lipoic Acid Treatment Chronic Kidney Disease (TALAT)

Chronic Kidney Disease

United States
Daiichi Sankyo, Inc.

Completed

Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension (Benibest)

Essential Hypertension
Sinovac Biotech Co., Ltd
Centers for Disease Control and Prevention, China

Completed

Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Children

Influenza

China
Vical

Completed

Pandemic Influenza Plasmid DNA Vaccines (Needle)

Influenza

United States
Solvay Pharmaceuticals

Terminated

Immunogenicity and Safety of Two Adjuvant Formulations of an Egg-Derived Pandemic Vaccine

Healthy Subjects

Finland, Germany
Novartis
Novartis Vaccines

Completed

Immunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adult and Elderly Subjects

Influenza

Poland
Sinovac Biotech Co., Ltd
Centers for Disease Control and Prevention, China

Completed

Safety and Immunogenicity of Booster Dose of An Inactivated,Adjuvanted Whole-Virion Pandemic Influenza(H5N1)Vaccine

Prevention | Pandemic Influenza | Pandemic Influenza Vaccine

China
Sinovac Biotech Co., Ltd
Ministry of Science and Technology of the People´s Republic of China

Completed

Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy Subjects

Influenza

China
Sinovac Biotech Co., Ltd
Centers for Disease Control and Prevention, China

Completed

Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine

Prevention | Pandemic Influenza
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two(Surface Antigen Adjuvanted With MF59C.1) Influenza Vaccines in Non-Elderly Adult and Elderly Subjects

Pandemic Influenza Disease

Italy
PowderMed

Completed

Safety Study of an Influenza Vaccine Against a Potential Pandemic Strain of Flu

Influenza (Pandemic)

United Kingdom
London School of Hygiene and Tropical Medicine
Medical Research Council; National Malaria Control Programme, The Gambia

Completed

Lapdap and Coartemether for Uncomplicated Malaria

Malaria

Gambia

Search clinical trials for: Pandemi

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations